Biotech event this November in Beijing

WASHINGTON – The Biotechnology Industry Organization (BIO) is pleased to announce that Washington State Gov. Jay Inslee will provide a keynote address at the 3rd annual BIO? Convention in China to be held November 11-13, 2013 in Beijing. The event will bring together a global audience of biotechnology executives, pharmaceutical companies and investment firms to meet and explore business opportunities within China’s emerging biotech sector. Gov. Inslee’s plenary keynote address will take place on Tuesday, November 12.

“We are thrilled that Governor Inslee will be joining us in China this year. The governor has been tireless in his efforts to foster Washington’s biotech and life sciences sector,” said Joseph Damond, senior vice president of international affairs at BIO. “During his time in the US House of Representatives, Governor Inslee was chosen as BIO’s Legislator of the Year for his efforts to create an approval pathway for biosimilars. His perspective will be invaluable as China seeks to grow its biologics and biosimilars industry.”

BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. Its members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products.

“China is a rapidly growing market for America’s innovative biotechnology companies, including those in Washington State,” said Governor Inslee. “As this market continues to expand, it will be increasingly important to develop collaborative relationships with the Chinese government, companies, and academic institutions. The BIO Convention is China is a wonderful venue to build those relationships, and I am very glad to be able to attend this year.”

The 3rd annual BIO Convention in China will feature workshops including science-focused sessions such as vaccines, unmet medical needs and the research and development of orphan drugs to treat rare diseases in China. Business-focused sessions will explore China’s private health care industry, early-stage VC funding in China, and partnering models between Chinese and Western companies. Convention programming and exhibition will take place November 12-13, 2013.

BIO brings to China more than 17 years of experience in organizing international conferences for the biotech industry, including the Air Zoom Pegasus 34 Leather